Our name "Sanomics" is derived from the word "sanguis", the Latin word for blood, and "genomics", which describes the study of genes. VISION Our principle of “Patient First” allows us to revolutionise current cancer treatments by providing safe and efficient liquid-based and tissue-based genomic tests. We aim to provide easy and convenient access to our services and help doctors decide a personalised cancer solution for patients. MISSION Based in Hong Kong, Sanomics continues expanding throughout South East Asia, with our first overseas branch opening in January of 2019 in Bangkok, Thailand. We work with health care professionals, clinics and pharmaceutical companies to develop the best care for our patients. As a pioneer in the pan-Asian genomics industry, we aspire to develop and use the latest genetic and genomic technologies to offer personalised medicine to our patients.